icon
icon
icon
icon
🏷️$300 Off
🏷️$300 Off

News /

Articles /

"AI Drug Discovery Platform TandemViz Joins Phoenix's SkyNet, Revolutionizing Access and Costs"

Coin WorldThursday, Feb 20, 2025 9:14 am ET
1min read

Phoenix, a decentralized AI compute network, has partnered with TandemAI, a leading AI drug discovery technology firm, to deploy TandemAI's state-of-the-art AI drug discovery platform, TandemViz, on Phoenix's AI compute layer, SkyNet. This collaboration will enable a custom, lightweight version of the platform to run on SkyNet's AI node network, allowing research organizations, labs, and pharmaceutical companies to utilize the system at zero cost and scale usage with significantly reduced costs.

AI drug discovery is a rapidly evolving field that has transformed clinical research and drug R&D by significantly lowering costs and development timelines. The partnership between Phoenix and TandemAI is notable for its business model innovation, making a high-cost, computationally intensive AI solution accessible to smaller entities such as individual researchers and labs. This integration is also unprecedented in the decentralized AI and DePIN space, as it deploys a critical use-case industry solution on decentralized architecture.

The partnership is also relevant to the burgeoning DeSci (decentralized science) space, as it can be enhanced and complemented by infusing industry-specific AI research tools. This broadens the scope of value delivered by DeSci players and opens up possibilities for DeSci DAOs to provide grants and funding for particular causes, subsidizing AI and computing infrastructure as well as software to advance research.

TandemAI, founded by industry veteran Lanny Sun, is one of the fastest-growing AI drug discovery firms. With over 350 employees and 50 award-winning AI and computational chemist scientists, TandemAI serves over 80 large pharmaceutical clients worldwide. Phoenix, an AI DePIN network for vertical industry applications, offers a highly scalable, low-waste, high-utilization compute layer that supports non-Nvidia-based edge computing and traditional high-performance GPU for AI. Backed by the $20 million Phoenix AI Ecosystem Fund, Phoenix accelerates innovation by fostering projects and applications within its growing AI ecosystem.

Comments

Add a public comment...
Post
User avatar and name identifying the post author
ashish1512
02/20
AI drug discovery speeding up. Lower costs, faster timelines. Pharma's new normal. Who's ready for the next breakthrough?
0
Reply
User avatar and name identifying the post author
Traglc
02/20
TandemViz's accessibility will boost innovation. Labs and researchers, unite! 🎉
0
Reply
User avatar and name identifying the post author
foureyedgrrl
02/20
Decentralized AI is the future. TandemAI and Phoenix are paving the way. Hope to see more DePIN use cases.
0
Reply
User avatar and name identifying the post author
ZestycloseAd7528
02/20
@foureyedgrrl What other DePIN use cases do you think could disrupt the industry?
0
Reply
User avatar and name identifying the post author
RadioactiveCobalt
02/20
Lanny Sun's got a winner with TandemAI. 350 employees and 50 AI chemists? That's a powerhouse.
0
Reply
User avatar and name identifying the post author
serenity561
02/20
Lanny Sun's move could disrupt Big Pharma.
0
Reply
User avatar and name identifying the post author
caollero
02/20
Holding $AAPL, but watching TandemAI's play.
0
Reply
User avatar and name identifying the post author
joe_bidens_underwear
02/20
SkyNet's got the juice for AI drug hunt.
0
Reply
User avatar and name identifying the post author
NavyGuyvet
02/20
Decentralized AI is the future, folks. 🚀
0
Reply
User avatar and name identifying the post author
Serious_Procedure_19
02/20
TandemViz on SkyNet? Game changer for pharma biz.
0
Reply
User avatar and name identifying the post author
AbuSaho
02/20
TandemViz free? Labs' dream come true.
0
Reply
User avatar and name identifying the post author
Ambitious_Orchid_239
02/20
SkyNet's custom AI node network is a genius move. Scalability and cost-effectiveness are key in pharma research.
0
Reply
User avatar and name identifying the post author
Hungry-Bee-8340
02/20
DeSci space getting infused with industry-specific AI tools. This partnership is a big deal for decentralized science.
0
Reply
User avatar and name identifying the post author
TheOSU87
02/20
@Hungry-Bee-8340 DeSci's future looks bright. This collab's a win.
0
Reply
User avatar and name identifying the post author
pellosanto
02/20
@Hungry-Bee-8340 Not sure "big deal" fits. It's just TandemViz, lol.
0
Reply
User avatar and name identifying the post author
Direct_Name_2996
02/20
TandemViz on SkyNet? Game changer for small players. AI drug discovery democratized. 🚀
0
Reply
User avatar and name identifying the post author
Dry_Entertainer_6727
02/20
$TSLA and $AAPL are my main holdings, but this partnership has me intrigued. Diversifying with TandemAI's potential.
0
Reply
User avatar and name identifying the post author
WorgenFurry
02/20
@Dry_Entertainer_6727 How long you been holding TSLA and AAPL? Curious if you're thinking to add TandemAI for long-term or short-term gains.
0
Reply
User avatar and name identifying the post author
vanilica00
02/20
@Dry_Entertainer_6727 I had TSLA, sold it too early man... regret not holding. Seeing this TandemAI deal makes me wish I stayed in.
0
Reply
User avatar and name identifying the post author
TenMillionYears
02/20
TandemViz on SkyNet is a game-changer. Decentralized AI can now tackle real-world problems at scale and low cost. 🚀
0
Reply
User avatar and name identifying the post author
Wonderful_Touch5652
02/20
@TenMillionYears What other impacts can this have?
0
Reply
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
You Can Understand News Better with AI.
Whats the News impact on stock market?
Its impact is
fork
logo
AInvest
Aime Coplilot
Invest Smarter With AI Power.
Open App